These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9182143)

  • 1. [Synergistic action of penicillin and immunoglobulin for intravenous (IVIG) use].
    Bucholc B; Banach W
    Med Dosw Mikrobiol; 1996; 48(3-4):201-10. PubMed ID: 9182143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced killing of group B streptococci in vitro by penicillin and opsonophagocytosis with intravenous immunoglobulin.
    Miller PS; Schauf V; Salo RJ
    J Infect Dis; 1990 Jun; 161(6):1225-30. PubMed ID: 2111840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
    Givner LB
    Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous gamma-globulin inhibits binding of anti-GM1 to its target antigen.
    Malik U; Oleksowicz L; Latov N; Cardo LJ
    Ann Neurol; 1996 Jan; 39(1):136-9. PubMed ID: 8572660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitis.
    Patel R; Rouse MS; Florez MV; Piper KE; Cockerill FR; Wilson WR; Steckelberg JM
    J Infect Dis; 2000 Jan; 181(1):230-4. PubMed ID: 10608771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotics.
    Fischer GW; Weisman LE
    Scand J Infect Dis Suppl; 1990; 73():17-21. PubMed ID: 2128662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiviral activity of IgG subclasses of immunoglobulin preparations for intravenous use].
    Litwińska B; Bucholc B; Biesiadecka A; Kańtoch M
    Med Dosw Mikrobiol; 1993; 45(4):523-8. PubMed ID: 8189834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.
    Pollreisz A; Assinger A; Hacker S; Hoetzenecker K; Schmid W; Lang G; Wolfsberger M; Steinlechner B; Bielek E; Lalla E; Klepetko W; Volf I; Ankersmit HJ
    Br J Dermatol; 2008 Sep; 159(3):578-84. PubMed ID: 18565176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
    Hiemstra PS; Brands-Tajouiti J; van Furth R
    J Lab Clin Med; 1994 Feb; 123(2):241-6. PubMed ID: 8301200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental endocarditis in rabbits. 6. Results of long-term combined therapy of Streptococcus faecalis endocarditis with penicillin and streptomycin.
    Gutschik E
    Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):37-47. PubMed ID: 6805250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of combined action of beta-lactame and aminoglycoside antibiotics on resistant strains of streptococcus group D.
    Zaremba L; Linda H; Dzierzanowska D
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):853-9. PubMed ID: 261659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillin-induced killing and postantibiotic effect in oral streptococci are enhanced by platelet microbicidal proteins.
    Lee SY; Choe SJ
    Int J Antimicrob Agents; 2004 May; 23(5):457-61. PubMed ID: 15120723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND; Munro CS; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance.
    Djurkovic S; Loeffler JM; Fischetti VA
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1225-8. PubMed ID: 15728935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of high dose intravenous immunoglobulin in neurologic disease].
    Korsak J; Zaleska B; Orłowska E; Kotowicz J
    Pol Merkur Lekarski; 2005 Jul; 19(109):98-101. PubMed ID: 16194039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
    Sriskandan S; Ferguson M; Elliot V; Faulkner L; Cohen J
    J Antimicrob Chemother; 2006 Jul; 58(1):117-24. PubMed ID: 16670109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opsonizing activity of human immunoglobulin preparations for intravenous use (IVIG)].
    Banach W; Bucholc B
    Med Dosw Mikrobiol; 1994; 46(4):349-55. PubMed ID: 7603135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.